Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex-Reference-Cited by-同舟云学术

Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex

Published:2024-05 Issue: Volume:343 Page:199356
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Kuzikov Maria^ORCID,Reinshagen Jeanette,Wycisk Krzysztof,Corona Angela,Esposito Francesca,Malune Paolo,Manelfi Candida,Iaconis Daniela,Beccari Andrea,Tramontano Enzo,Nowotny Marcin,Windshügel Björn,Gribbon Philip,Zaliani Andrea

Funder

Horizon 2020

Publisher

Elsevier BV

Reference55 articles.

1. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase;Adedeji;Antimicrob. Agents Chemother.,2012

2. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses;Adedeji;Antimicrob. Agents Chemother.,2014

3. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates;Ahn;Arch. Virol.,2012

4. DNA binding characteristics of mithramycin and chromomycin analogues obtained by combinatorial biosynthesis;Barceló;Biochemistry,2010

5. Natural compounds inhibit SARS-CoV2 Nsp13 unwinding and ATPase enzyme activities;Corona;ACS Publ. J. Contrib.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variable Inhibition of DNA Unwinding Rates Catalyzed by the SARS-CoV-2 Helicase Nsp13 by Structurally Distinct Single DNA Lesions;International Journal of Molecular Sciences;2024-07-19